4//SEC Filing
Burkly Linda 4
Accession 0001650664-25-000091
CIK 0001650664other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 6:37 PM ET
Size
5.5 KB
Accession
0001650664-25-000091
Insider Transaction Report
Form 4
Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Stock
2025-06-03$1.72/sh−726$1,252→ 69,519 total
Footnotes (2)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7522. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001985604
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 6:37 PM ET
- Size
- 5.5 KB